Skip To Main Content
Herbert Lepor on Muck Rack

Herbert Lepor

New York
As seen in: HuffPost, Nature, New York Post, Healio Primary Care, CURE Magazine, ONCOLOGY journal, Citeline, OncLive, European Urology, UroToday and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Herbert

Contact Herbert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Q&A: Advances in prostate cancer treatment underscore need for screening Original

|
By Andrew Rhoades Verified, Herbert Lepor
| Healio Primary Care Verified
September 03, 2026 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request.
Open in Who Shared View Duplicates (2) Issue with article?

Herbert Lepor, MD

|
By Herbert Lepor
| ONCOLOGY journal Verified
Herbert Lepor, MD, outlines NYU Langone’s long-term PSA and MRI surveillance protocol following focal cryoablation for prostate cancer. ByHerbert Lepor, MD,Nicholas M.
Open in Who Shared Issue with article?

Focal Cryo-ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate Cancer - Beyond the Abstract

|
By Herbert Lepor, Jared Fiske, Majlinda Tafa
| UroToday Verified
An increasing proportion of kidney, bladder, ureteral, and penile cancers are managed with organ preserving strategies. Historically, prostate cancer was not managed with organ sparing strategies since transrectal random systematic biopsy did not identify the site(s) of cancer and the disease was often multifocal.
Open in Who Shared Issue with article?
See all 17 licensed articles (26 Total)